The roles of NF-κB in severe respiratory diseases such as septic ALI and ARDS have been well documented, and thus numerous therapeutic strategies to cure ALI/ARDS have largely hinged on curbing NF-κB activity. Here, NFKB1 is linked to acute respiratory distress syndrome.